Mon - Fri 09:00-18:00 0207 060 3773
Email info@boundarycapital.com

Day

January 8, 2016
Boundary Capital Partners joins syndicate and Illumina to invest in Desktop Genetics’ technology to support the platform’s integration with NGS pipelines and improve CRISPR genome editing workflows. Desktop Genetics Ltd (“DTG” or “the Company”), a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding from...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases